Over the years of experience in the industry, we are engaged in offering a range of precise formulation Venetoclax Intermediates CAS 1228780-72-0 to our customers. Venetoclax is a small molecule oral drug being investigated to treat chronic lymphocytic leukemia. In order to ensure Venetoclax Intermediates CAS NO 1228780-72-0 is secure and precise, we manufacture the intermediate of Venetoclax from finest ingredients using cutting edge technology and advanced machinery. The packaging of the Venetoclax Intermediates 1228780-72-0 is tamper proof and water resilient that makes the goods easy to store and deliver.

Thera. Category: Anti-tumor

Cas No.: 1228780-72-0

Synonym: 1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine;1-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazine dihydrochloride salt;1-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl)methyl)piperazine

Molecular Formula: C19H27ClN2

Molecular Weight:318.88

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage: ABT-199 Intermediates

Related Product:
CAS 1228779-96-1, 3-nitro-4-((tetrahydro-2H-pyran-4-yl)MethylaMino)benzenesulfonaMide
CAS 1228780-72-0, 1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine